Patent details
300981
Product Name:
Doravirine, desgewenst in de vorm van een farmaceutisch aanvaardbaar
zout in combinatie met lamivudine, desgewenst in de vorm van een
farmaceutisch aanvaardbaar zout, in combinatie met tenofovir of een ester
daarvan, in het bijzonder een disoproxil ester, desgewenst in de vorm van
een farmaceutisch aanvaardbaar zout, in het bijzonder een fumaraat zout
The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
Ok
Cancel
You have not selected any documents
Ok
Basic Information
Publication number:
300981
Type:
Certificate
SPC Type:
Medical
Basic Patent Number:
EP2924034
Status:
Application Pending
Application number:
300981
Procedural language:
Dutch
First Applicant Residence Country:
Canada (CA)
Marketing Authorization
Marketing Authorization Number:
EU/1/18/1333/001-002
Marketing Authorization Type:
EEA
Marketing Authorization Date:
26/11/2018
Marketing Authorization Country:
European Union (EU)
Dates
Filing date:
16/04/2019
First Marketing Authorization date:
26/11/2018
Grant date:
Activation date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Registration date:
17/04/2019
SPC/SPC Extension Expiration Date:
Lapsed By Expiration Date:
Withdrawal date:
Revocation Date:
Invalidity Date:
Withdrawal Market Authorization Date:
Refusal Date:
Applicant/holder
From:
17/04/2019
Name:
Merck Canada Inc.
Address:
16711 Trans-Canada Highway, KIRKLAND, QC H9H 3L1, Canada (CA)
Agent
1
Name:
dr. R.C. van Duijvenbode c.s.
From:
07/11/2025
Address:
NLO
Postbus 29720, 2502 LS, Den Haag, Netherlands (NL)
To:
2
Name:
ir. M.F.J.M. Ketelaars c.s.
From:
17/04/2019
Address:
NLO
Postbus 29720, 2502 LS, Den Haag, Netherlands (NL)
To:
07/11/2025
Publication
Bulletin
Bulletin Heading:
SPC
Journal edition number:
17/19
Publication date:
24/04/2019
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)
Filing date
Document type
Document Description
Number of pages
File Type
18/04/2019
Outgoing Correspondence
Confirmation receipt request
1
PDF
/3/6/0/0/0/0800400063/docs/300981_4_267435l174.pdf
16/04/2019
SPC Documents
Marketing Authorization SPC
3
PDF
/3/6/0/0/0/0800400063/docs/300981_0_supplprotectioncertificate20190417114532202.pdf
16/04/2019
SPC Documents
Annex SPC
1
PDF
/3/6/0/0/0/0800400063/docs/300981_1_supplprotectioncertificate20200608030023056.pdf
16/04/2019
SPC Documents
Summary of the characteristics of the product
29
PDF
/3/6/0/0/0/0800400063/docs/300981_2_supplprotectioncertificate20190417114532285.pdf
16/04/2019
SPC Documents
Annex SPC
2
PDF
/3/6/0/0/0/0800400063/docs/300981_3_supplprotectioncertificate20190417114532369.pdf
16/04/2019
SPC Documents
Annex SPC
15
PDF
/3/6/0/0/0/0800400063/docs/300981_5_supplprotectioncertificate20190417114532462.pdf
16/04/2019
Application Form
First filed application form
2
PDF
/3/6/0/0/0/0800400063/docs/300981_6_applicationform20190417114531672.pdf